Juan Francisco
Navarro González
Investigador Externo
Instituto de Salud Carlos III
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Salud Carlos III (29)
2023
-
Association of Klotho with Coronary Artery Disease in Subjects with Type 2 Diabetes Mellitus and Preserved Kidney Function: A Case-Control Study
International Journal of Molecular Sciences, Vol. 24, Núm. 17
-
Associations between Inflammation, Hemoglobin Levels, and Coronary Artery Disease in Non-Albuminuric Subjects with and without Type 2 Diabetes Mellitus
International journal of molecular sciences, Vol. 24, Núm. 18
-
Klotho inversely relates with carotid intima- media thickness in atherosclerotic patients with normal renal function (eGFR ≥60 mL/min/1.73m2): a proof-of-concept study
Frontiers in Endocrinology, Vol. 14
-
Klotho, Oxidative Stress, and Mitochondrial Damage in Kidney Disease
Antioxidants, Vol. 12, Núm. 2
-
Mineral and bone metabolism markers and mortality in diabetic patients on haemodialysis
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 38, Núm. 11, pp. 2589-2597
-
Targeting inflammation to treat diabetic kidney disease: the road to 2030
Kidney International, Vol. 103, Núm. 2, pp. 282-296
-
The Value of Klotho in Kidney Transplantation
Transplantation, Vol. 107, Núm. 3, pp. 616-627
2022
-
Electronic Patient-Reported Outcomes in Nephrology: Focus on Hemodialysis
Journal of Clinical Medicine, Vol. 11, Núm. 3
-
Osteoporosis in chronic kidney disease: A essential challenge
Medicina Clinica, Vol. 158, Núm. 1, pp. 27-34
-
Repurposing drugs for highly prevalent diseases: pentoxifylline, an old drug and a new opportunity for diabetic kidney disease
Clinical Kidney Journal, Vol. 15, Núm. 12, pp. 2200-2213
-
Silver jubilee: 25 years of the first demonstration of the direct effect of phosphate on the parathyroid cell
Nefrologia, Vol. 42, Núm. 6, pp. 645-655
-
Sodium-glucose co-transporter-2 inhibitors increase Klotho in patients with diabetic kidney disease: A clinical and experimental study
Biomedicine and Pharmacotherapy, Vol. 154
-
The unmet need of evidence-based therapy for patients with advanced chronic kidney disease and heart failure
Clinical Kidney Journal, Vol. 15, Núm. 5, pp. 865-872
2021
-
Interleukin-17A: Potential mediator and therapeutic target in hypertension
Nefrologia
-
Interleuquina-17A: posible mediador y diana terapéutica en la hipertensión
Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, Vol. 41, Núm. 3, pp. 244-257
-
Klotho as a biomarker of subclinical atherosclerosis in patients with moderate to severe chronic kidney disease
Scientific Reports, Vol. 11, Núm. 1
-
Mortality in hemodialysis patients with covid-19, the effect of paricalcitol or calcimimetics
Nutrients, Vol. 13, Núm. 8
-
Optimizing the timing of nephrology referral for patients with diabetic kidney disease
Clinical Kidney Journal, Vol. 14, Núm. 1, pp. 5-8
-
Real-world management of hyperphosphataemia with sucroferric oxyhydroxide: The VELREAL multicentre study
Clinical Kidney Journal, Vol. 14, Núm. 2, pp. 681-687
-
Setting up a cardiorenal clinic. Consensus document of the cardiorenal working groups of the Spanish Society of Cardiology and the Spanish Society of Nephrology
REC: CardioClinics, Vol. 56, Núm. 4, pp. 284-295